Search results
Results from the WOW.Com Content Network
Telcagepant (code name MK-0974) is a calcitonin gene-related peptide receptor antagonist which was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co. [1] In the acute treatment of migraine, it was found to have equal efficacy to rizatriptan [2] and zolmitriptan. [3]
telcagepant (USAN, INN) Teldrin (Gemini Pharmaceuticals) telenzepine ; Telepaque (Sterling-Winthrop) telimomab aritox ; telinavir ; telithromycin ;
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Calcitonin gene-related peptide (CGRP) receptor antagonists are a class of drugs that act as antagonists of the calcitonin gene-related peptide receptor (CGRPR). [1]Several monoclonal antibodies that bind to the CGRP receptor or peptide have been approved for prevention of migraine. [2]
A 2013 meta-analysis found olcegepant and telcagepant were effective and safe compared to placebo. [3] See also. Telcagepant; References This ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Endogenous: Adrenomedullin Apelin; Asprosin; Bombesin; Calcitonin; Carnosine; CART; CLIP; DSIP; Enteroglucagon; Formyl peptide; GALP; GIP; GRP; Integrin ligands ...
Telcagepant; Usage on www.wikidata.org Q5675567; Metadata. This file contains additional information, probably added from the digital camera or scanner used to create ...